News

• Sanofi-aventis News

  (posted 2 weeks, 6 days ago)

• Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease

  (posted 2 weeks, 6 days ago)

• Memory Pharmaceuticals Presents Positive Preclinical Data for MEM 68626 at ICAD 2008

  (posted 3 weeks ago)

• Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease

  (posted 3 weeks ago)

• Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients

  (posted 3 weeks ago)

• New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans

  (posted 3 weeks, 2 days ago)

• BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Out

  (posted 3 weeks, 2 days ago)

• Nventa Announces Final Data from HspE7 Phase 1 Cervical Dysplasia Trial

  (posted 3 weeks, 2 days ago)

• First Half 2008 Financial Results: NicOx Nears Completion of Phase 3 Naproxcinod Studies

  (posted 3 weeks, 2 days ago)

• Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit

  (posted 3 weeks, 5 days ago)

Result Page: 1 2 3 4 5 6 7 8 9 10 Next